Difference between revisions of "Marsicano G"
From Bioblast
Beno Marija (talk | contribs) |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | |||
|COST= Member | |||
}} | |||
{{Person | {{Person | ||
|lastname=Marsicano | |lastname=Marsicano |
Latest revision as of 09:20, 11 November 2016
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Marsicano G
MitoPedia topics: EAGLE
COST: Member
Name | Marsicano Giovanni, DVM, PhD |
---|---|
Institution | Giovanni Marsicano DVM, PhD
NeuroCentre Magendie U862 INSERM Université Bordeaux 2 Group "Endocannabinoids and Neuroadaptation" |
Address | 146, rue Léo Saignat, 33077 |
City | Bordeaux |
State/Province | |
Country | France |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Haney 2023 Nat Med | 2023 | Haney M, Vallée M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, Cathala A, Bari A, Serrat R, Finlay DB, Caraci F, Redon B, Martín-García E, Busquets-Garcia A, Matias I, Levin FR, Felpin FX, Simon N, Cota D, Spampinato U, Maldonado R, Shaham Y, Glass M, Thomsen LL, Mengel H, Marsicano G, Monlezun S, Revest JM, Piazza PV (2023) Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. https://doi.org/10.1038/s41591-023-02381-w |